Biden-era policies rescinded by Donald Trump could signal a significant shake-up in Medicare and Medicaid drug price reforms.

The Centers for Medicare and Medicaid Services ("CMS") published a final notice outlining the processes and procedures for the Transitional ...

The AP-NORC poll shows about half of Americans “strongly” or “somewhat” favor having the federal programs Medicare and ...

The pause appears to apply to HHS agencies such as the U.S. Food and Drug Administration, the Centers for Medicare and Medicaid Services, the U.S. Centers for Disease Control and Prevention ...

Bill to pay for multi-cancer early detection screening test has bipartisan support, but just ran out of time last session.

along with another program that would see Medicare pay less for drugs that receive accelerated approval from the Food and Drug Administration. The cell- and gene-therapy program, meanwhile ...

President Donald Trump has nominated Kennedy to be the secretary of the U.S. Department of Health and Human Services, which ...

these products are not considered generic versions and are not approved by the Food and Drug Administration. CMS had until Feb. 1 to publish the next round of drugs chosen for Medicare negotiation.

Robert F. Kennedy Jr., if confirmed as HHS secretary, could help food-as-medicine startups expand with wider government ...